Nuzenio

Summit Therapeutics Further

Summit Therapeutics Further news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

event 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Did Expanding Ivonescimab Into First-Line Bladder Cancer Just Shift Summit Therapeutics' (SMMT) Investment Narrative? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 22:09:14 GMT Summit Therapeutics (NASDAQ: SMMT) launches Phase II/III HARMONi-GU1 bladder cancer study - Stock TitanStock Titan · Wed, 05 Aug 2026 11:32:48 GMT Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer - Business WireBusiness Wire · Wed, 05 Aug 2026 11:00:00 GMT Summit Therapeutics: Upgrading To Hold As Critical Approval Decision Approaches (SMMT) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMT Summit Therapeutics upgraded to Hold as FDA rev... - PluangPluang · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 22:09:14 GMTDid Expanding Ivonescimab Into First-Line Bladder Cancer Just Shift Summit Therapeutics' (SMMT) Investment Narrative? - simplywall.st

Wed, 05 Aug 2026 11:32:48 GMTSummit Therapeutics (NASDAQ: SMMT) launches Phase II/III HARMONi-GU1 bladder cancer study - Stock Titan

Wed, 05 Aug 2026 11:00:00 GMTSummit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer - Business Wire

Fri, 31 Jul 2026 07:00:00 GMTSummit Therapeutics: Upgrading To Hold As Critical Approval Decision Approaches (SMMT) - Seeking Alpha

Fri, 31 Jul 2026 07:00:00 GMTSummit Therapeutics upgraded to Hold as FDA rev... - Pluang

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

SMMT6 live mentions Therapeutics4 live mentions Phase II4 live mentions III HARMONi4 live mentions Summit Therapeutics3 live mentions Did Expanding Ivonescimab2 live mentions Into First2 live mentions Line Bladder Cancer2 live mentions Just Shift Summit2 live mentions Investment Narrative2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Summit Therapeutics Further.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.